| RS2505099370 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505099397 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505099559 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505120564 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505136920 |
SLC12A1
|
Health Risk |
Likely pathogenic |
— |
| RS2505137296 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505137368 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505141958 |
SLC12A1
|
Health Risk |
Likely pathogenic |
— |
| RS2505162652 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505163374 |
OCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tyrosinase-positive oculocutaneous albinism, Tyrosinase-positive oculocutaneous albinism |
| RS2505163641 |
OCA2
|
Health Risk |
Pathogenic |
— |
| RS2505172270 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505173672 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505176651 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505177370 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia, Hereditary spastic paraplegia 11 |
| RS2505182645 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505184483 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2505184605 |
MESP2
|
Health Risk |
Pathogenic |
Spondylocostal dysostosis 2, autosomal recessive |
| RS2505184685 |
MESP2
|
Health Risk |
Pathogenic |
Spondylocostal dysostosis 2, autosomal recessive |
| RS2505184696 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2505184851 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2505185403 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2505185436 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2505185579 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2505185594 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2505185703 |
SPG11
|
Health Risk |
Likely pathogenic |
— |
| RS2505185716 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2505185781 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2505185956 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2505186262 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2505186780 |
SPG11
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2505187482 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS2505190299 |
SLC12A1
|
Health Risk |
Likely pathogenic |
Bartter syndrome, Bartter syndrome |
| RS2505190434 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505191463 |
SLC12A1
|
Health Risk |
Likely pathogenic |
— |
| RS2505192006 |
SLC12A1
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS2505197931 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505205547 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505206459 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505207581 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS2505209009 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505209286 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505210242 |
SMAD3
|
Health Risk |
Likely pathogenic |
Aneurysm-osteoarthritis syndrome, Aneurysm-osteoarthritis syndrome |
| RS2505213278 |
SMAD3
|
Health Risk |
Likely pathogenic |
Aneurysm-osteoarthritis syndrome, Aneurysm-osteoarthritis syndrome |
| RS2505218930 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505218935 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505219470 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505220763 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS2505221112 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505221117 |
ACAN
|
Health Risk |
Likely pathogenic |
Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans |
| RS2505221225 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505221578 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505222600 |
SMAD3
|
Health Risk |
Likely pathogenic |
SMAD3-related disorder, SMAD3-related disorder |
| RS2505222700 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505222846 |
ACAN
|
Health Risk |
Likely pathogenic |
— |
| RS2505223192 |
ACAN
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Short stature and advanced bone age |
| RS2505223464 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS2505225464 |
SLC12A1
|
Health Risk |
Pathogenic |
— |
| RS2505225672 |
SLC12A1
|
Health Risk |
Likely pathogenic |
SLC12A1-related disorder, SLC12A1-related disorder |
| RS2505227410 |
MEIS2
|
Health Risk |
Likely pathogenic |
Cardiac malformation, cleft lip/palate |
| RS2505229146 |
SPG11
|
Health Risk |
Likely pathogenic |
SPG11-related disorder, SPG11-related disorder |
| RS2505229373 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505229607 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505229934 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505230282 |
SPG11
|
Health Risk |
Likely pathogenic |
SPG11-related disorder, SPG11-related disorder |
| RS2505230922 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS2505231171 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS2505238309 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505238680 |
ABCD4
|
Health Risk |
Pathogenic |
Methylmalonic acidemia with homocystinuria, type cblJ |
| RS2505239376 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505239464 |
SPG11
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS2505239545 |
SMAD3
|
Health Risk |
Likely pathogenic |
Aneurysm-osteoarthritis syndrome, Aneurysm-osteoarthritis syndrome |
| RS2505239786 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505240838 |
ACAN
|
Health Risk |
Likely pathogenic |
— |
| RS2505241670 |
ACAN
|
Health Risk |
Pathogenic |
Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans |
| RS2505242245 |
ACAN
|
Health Risk |
Likely pathogenic |
Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans |
| RS2505246796 |
MEIS2
|
Health Risk |
Likely pathogenic |
MEIS2-related disorder, MEIS2-related disorder |
| RS2505250008 |
ACAN
|
Health Risk |
Likely pathogenic |
— |
| RS2505250018 |
ACAN
|
Health Risk |
Pathogenic |
Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans |
| RS2505251299 |
ACAN
|
Health Risk |
Likely pathogenic |
ACAN-related disorder, ACAN-related disorder |
| RS2505251328 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS2505260952 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS2505261152 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS2505261482 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS2505263453 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS2505270713 |
MEIS2
|
Health Risk |
Pathogenic |
Cardiac malformation, cleft lip/palate |
| RS2505271040 |
MEIS2
|
Health Risk |
Pathogenic |
— |
| RS2505271823 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS2505272471 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS2505275760 |
ACAN
|
Health Risk |
Pathogenic |
— |
| RS2505278859 |
OCA2
|
Health Risk |
Likely pathogenic |
— |
| RS2505282185 |
OCA2
|
Health Risk |
Likely pathogenic |
SKIN/HAIR/EYE PIGMENTATION 1, BLUE/NONBLUE EYES |
| RS2505282696 |
SMAD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505282768 |
SMAD3
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505282958 |
SMAD3
|
Health Risk |
Likely pathogenic |
Aneurysm-osteoarthritis syndrome, Aneurysm-osteoarthritis syndrome |
| RS2505283146 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505283231 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505283996 |
SMAD3
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2505284032 |
SMAD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Aneurysm-osteoarthritis syndrome |
| RS2505284100 |
SMAD3
|
Health Risk |
Likely pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |